Performance Evaluation of the SAMBA II SARS-CoV-2 Test for Point-of-Care Detection of SARS-CoV-2
- PMID: 33051242
- PMCID: PMC7771448
- DOI: 10.1128/JCM.01262-20
Performance Evaluation of the SAMBA II SARS-CoV-2 Test for Point-of-Care Detection of SARS-CoV-2
Abstract
Nucleic acid amplification for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in respiratory samples is the standard method for diagnosis. The majority of this testing is centralized and therefore has turnaround times of several days. Point-of-care (POC) testing with rapid turnaround times would allow more effective triage in settings where patient management and infection control decisions need to be made rapidly. The inclusivity and specificity of the Simple AMplification-Based Assay (SAMBA) II SARS-CoV-2 test were determined by both in silico analyses of the primers and probes and wet testing. The SAMBA II SARS-CoV-2 test was evaluated for performance characteristics. Clinical performance was evaluated in residual combined throat/nose swabs and compared to that of the Public Health England real-time PCR assay targeting the RdRp gene. The SAMBA II SARS-CoV-2 test has an analytical sensitivity of 250 copies/ml for detecting two regions of the genome (open reading frame 1ab [ORF1ab] and nucleocapsid protein [N]). The clinical performance was evaluated in 172 residual combined nose/throat swabs provided by the Clinical Microbiology and Public Health Laboratory, Addenbrooke's Hospital, Cambridge (CMPHL), which showed an estimated positive percent agreement of 98.9% (95% confidence interval [CI], 93.83 to 99.97) and negative percent agreement of 96.4% (95% CI, 89.92 to 99.26) compared to testing by the CMPHL. The data show that the SAMBA II SARS-CoV-2 test performs equivalently to the centralized testing methods, but with a shorter turnaround time of 86 to 101 min. Point-of-care tests such as SAMBA should enable rapid patient management and effective implementation of infection control measures.
Keywords: COVID-19; SAMBA II; SARS-CoV-2; point of care.
Copyright © 2020 Assennato et al.
Figures
Similar articles
-
Development and comparison of novel multiple cross displacement amplification (MCDA) assays with other nucleic acid amplification methods for SARS-CoV-2 detection.Sci Rep. 2021 Jan 21;11(1):1873. doi: 10.1038/s41598-021-81518-8. Sci Rep. 2021. PMID: 33479389 Free PMC article.
-
Development, evaluation of the PNA RT-LAMP assay for rapid molecular detection of SARS-CoV-2.Sci Rep. 2021 Oct 14;11(1):20471. doi: 10.1038/s41598-021-00041-y. Sci Rep. 2021. PMID: 34650067 Free PMC article.
-
Comparing two sample pooling strategies for SARS-CoV-2 RNA detection for efficient screening of COVID-19.J Med Virol. 2021 May;93(5):2805-2809. doi: 10.1002/jmv.26632. Epub 2021 Mar 11. J Med Virol. 2021. PMID: 33107614
-
Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: A systematic review and meta-analysis.J Med Virol. 2021 Jul;93(7):4523-4531. doi: 10.1002/jmv.26994. Epub 2021 May 3. J Med Virol. 2021. PMID: 33913533 Free PMC article.
-
Loop-mediated isothermal amplification (LAMP): An effective molecular point-of-care technique for the rapid diagnosis of coronavirus SARS-CoV-2.Rev Med Virol. 2021 Nov;31(6):e2215. doi: 10.1002/rmv.2215. Epub 2021 Jan 21. Rev Med Virol. 2021. PMID: 33476080 Free PMC article. Review.
Cited by
-
Performance Evaluation of the MatMaCorp COVID-19 2SF Assay for the Detection of SARS-CoV-2 from Nasopharyngeal Swabs.Microbiol Spectr. 2021 Sep 3;9(1):e0008321. doi: 10.1128/Spectrum.00083-21. Epub 2021 Aug 11. Microbiol Spectr. 2021. PMID: 34378961 Free PMC article.
-
Establishment of Sample-to-Answer Loop-Mediated Isothermal Amplification-Based Nucleic Acid Testing Using the Sampling, Processing, Incubation, Detection and Lateral Flow Immunoassay Platforms.Biosensors (Basel). 2024 Dec 13;14(12):609. doi: 10.3390/bios14120609. Biosensors (Basel). 2024. PMID: 39727874 Free PMC article.
-
Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.Cochrane Database Syst Rev. 2021 Mar 24;3(3):CD013705. doi: 10.1002/14651858.CD013705.pub2. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 Jul 22;7:CD013705. doi: 10.1002/14651858.CD013705.pub3. PMID: 33760236 Free PMC article. Updated.
-
The QuantuMDx Q-POC SARS-CoV-2 RT-PCR assay for rapid detection of COVID-19 at point-of-care: preliminary evaluation of a novel technology.Sci Rep. 2023 Jun 17;13(1):9827. doi: 10.1038/s41598-023-35479-9. Sci Rep. 2023. PMID: 37330592 Free PMC article.
-
Samba II PCR testing for COVID-19 in pregnant women: a retrospective cohort study and literature review.BMC Pregnancy Childbirth. 2021 Mar 17;21(1):212. doi: 10.1186/s12884-021-03653-4. BMC Pregnancy Childbirth. 2021. PMID: 33731037 Free PMC article. Review.
References
-
- Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497–506. doi:10.1016/S0140-6736(20)30183-5. - DOI - PMC - PubMed
-
- Center for Systems Science and Engineering (CSSE) at John Hopkins University (JHU). 2020. COVID-19 dashboard. John Hopkins University, Baltimore, MD.
-
- Grzelak L, Temman S, Plachais C, Grzelak L, Temmam S, Planchais C, Demeret C, Huon C, Guivel F, Staropoli I, Chazal M, Dufloo J, Planas D, Buchrieser J, Rajah MM, Robinot R, Porrot F, Albert M, Chen K, Crescenzo B, Donati F, Anna F, Souque P, Gransagne M, Bellalou J, Nowakowski M, Backovic M, Bouadma l, Le Fevre L, Le Hingrat Q, Descamps D, Pourbaix A, Yazdanpanah Y, Tondeur L, Besombes C, Ungeheuer M, Mellon G, Morel P, Rolland S, Rey F, Behillil S, Enouf V, Lemaitre A, Creach M, Petres S, Escriou N, Charneau P, Fontanet A, Hoen B, Bruel T, et al. 2020. SARS-CoV-2 serological analysis of COVID-19 hospitalized patients, pauci-symptomatic individuals and blood donors. medRxiv doi:10.1101/2020.04.21.20068858. - DOI
-
- Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, Bleicker T, Brnink S, Schneider J, Schmidt ML, Mulders DGJC, Haagmans BL, van der Veer B, van den Brink S, Wijsman L, Goderski G, Romette J-L, Ellis J, Zambon M, Peirlis M, Goossens H, Reusken C, Koopmans MPG, Drosten C. 2020. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 25(3):pii=2000045. doi:10.2807/1560-7917.ES.2020.25.3.2000045. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous